NCR Atleos Corporation NATL 深 滬
已收盤 02-06 16:00:00 美东时间
40.17
+1.880
+4.91%
華盛通- 最 高40.41
- 今 開38.68
- 成交量 35.36万股
- 最 低 38.68
- 昨 收 38.29
- 總市值 29.69亿
- 52周最高 42.23
- 市盈率 靜 37.26
- 換手率 0.48%
- 52周最低 22.30
- 委 比 33.33%
- 總股本 7390.41万
- 歷史最高 42.23
- 量 比 0.96
- 振 幅 4.52%
- 歷史最低 18.415
- 每 手 1
- 風險率 5.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多NCR Atleos Unveils AI-Designed Dual-Sided ATM Concept
NCR Atleos Unveils AI-Designed Dual-Sided ATM Concept NCR Atleos Corporation has announced advancements in its dual-sided ATM concept, utilizing AI-assisted design to optimize the machine’s form factor, sustainability, and operational efficiency. The new design features two functional screens on opp
01-28 01:33
NCR Atleos Names Rohan Pal Chief Information Officer
NCR Atleos Names Rohan Pal Chief Information Officer NCR Atleos Corporation has appointed Rohan Pal as Chief Information Officer. Pal brings over 25 years of experience in technology strategy, digital transformation, IT modernization, cybersecurity, and cloud solutions. Before joining Atleos, he hel
01-26 20:31
NCR Atleos Corporation to Release Fourth Quarter and Full Year Earnings Results
NCR Atleos Corporation to Release Fourth Quarter and Full Year Earnings Results NCR Atleos Corporation will release its fourth quarter and full year 2025 financial results after market close on Thursday, February 26, 2026. Management will host a conference call to discuss the results on Friday, Febr
01-22 05:06
What's Driving the Market Sentiment Around NCR Atleos Corp?
NCR Atleos Corp's (NYSE:NATL) short interest as a percent of float has risen 3....
2025-12-13 03:00
NCR Atleos Updates Bylaws to Enhance Governance
An announcement from NCR Atleos, LLC ( ($NATL) ) is now available. On October 2...
2025-10-29 04:52
NCR Atleos Highlights Growth at Investor Conference
NCR Atleos, LLC ( ($NATL) ) just unveiled an update. NCR Atleos, LLC announced ...
2025-09-03 18:47
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
2025-08-11 09:43
Stifel Maintains Hold on NCR Atleos, Raises Price Target to $37
Stifel analyst Shlomo Rosenbaum maintains NCR Atleos (NYSE:NATL) with a Hold and raises the price target from $32 to $37.
2025-08-08 22:18
NCR Atleos Raises FY2025 Adj EPS Guidance from $3.22 to $3.90-$4.09 vs $3.97 Est; Widens FY2025 Sales Guidance from $4.317B to $4.300B-$4.426B vs $4.308B Est
NCR Atleos (NYSE:NATL) raises FY2025 Adj EPS guidance from $3.22 to $3.90-$4.09 vs $3.97 analyst estimate. Widens FY2025 sales outlook from $4.317 billion to $4.300 billion-$4.426 billion vs $4.308 billion estimate.
2025-08-07 04:24
Reported Earlier: NCR Atleos Expands Partnership With FCTI To Deploy Thousands Of ATMs Across U.S. Retail Locations
NCR Atleos Corporation (NYSE:NATL) ("Atleos"), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced a deeper relationship with FCTI, Inc., to provide
2025-08-07 00:09
